GE HealthCare Technologies Inc. $GEHC Shares Acquired by Sound Shore Management Inc CT

Sound Shore Management Inc CT boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 14.6% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 980,756 shares of the company’s stock after purchasing an additional 125,062 shares during the quarter. GE HealthCare Technologies comprises 2.4% of Sound Shore Management Inc CT’s holdings, making the stock its 27th biggest position. Sound Shore Management Inc CT owned approximately 0.22% of GE HealthCare Technologies worth $73,655,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in shares of GE HealthCare Technologies by 1.4% during the second quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock valued at $3,859,622,000 after buying an additional 703,903 shares during the last quarter. Dodge & Cox raised its stake in GE HealthCare Technologies by 42.1% during the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after acquiring an additional 6,982,441 shares in the last quarter. State Street Corp raised its stake in GE HealthCare Technologies by 1.9% during the 2nd quarter. State Street Corp now owns 19,660,742 shares of the company’s stock valued at $1,456,271,000 after acquiring an additional 372,755 shares in the last quarter. Geode Capital Management LLC boosted its position in GE HealthCare Technologies by 2.0% during the 2nd quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company’s stock worth $881,060,000 after acquiring an additional 231,302 shares during the period. Finally, Norges Bank bought a new position in shares of GE HealthCare Technologies in the second quarter worth $468,120,000. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on GEHC. Bank of America upped their price objective on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a report on Monday, January 5th. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and boosted their price target for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th. The Goldman Sachs Group reiterated a “buy” rating and issued a $98.00 price objective on shares of GE HealthCare Technologies in a report on Friday, January 9th. Citigroup boosted their target price on GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Finally, BTIG Research upped their target price on GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a research report on Wednesday, February 4th. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $92.50.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC opened at $79.20 on Thursday. The stock’s fifty day simple moving average is $82.62 and its 200 day simple moving average is $77.59. The stock has a market capitalization of $36.10 billion, a price-to-earnings ratio of 17.37, a PEG ratio of 1.75 and a beta of 1.08. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. The business had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.GE HealthCare Technologies’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter last year, the company posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio is 3.07%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.